Amicus Therapeutics, Inc. (DELISTED) (FOLD:DL)
14.49
0.00 (0.00%)
USD |
NASDAQ |
May 07, 16:00
Amicus Therapeutics Market Cap : 4.550B for May 7, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| May 07, 2026 | 4.550B |
| May 06, 2026 | 4.550B |
| May 05, 2026 | 4.550B |
| May 04, 2026 | 4.550B |
| May 01, 2026 | 4.550B |
| April 30, 2026 | 4.550B |
| April 29, 2026 | 4.550B |
| April 28, 2026 | 4.550B |
| April 27, 2026 | 4.550B |
| April 24, 2026 | 4.550B |
| April 23, 2026 | 4.540B |
| April 22, 2026 | 4.540B |
| April 21, 2026 | 4.540B |
| April 20, 2026 | 4.540B |
| April 17, 2026 | 4.540B |
| April 16, 2026 | 4.537B |
| April 15, 2026 | 4.540B |
| April 14, 2026 | 4.540B |
| April 13, 2026 | 4.540B |
| April 10, 2026 | 4.540B |
| April 09, 2026 | 4.544B |
| April 08, 2026 | 4.540B |
| April 07, 2026 | 4.544B |
| April 06, 2026 | 4.537B |
| April 02, 2026 | 4.534B |
| Date | Value |
|---|---|
| April 01, 2026 | 4.534B |
| March 31, 2026 | 4.540B |
| March 30, 2026 | 4.531B |
| March 27, 2026 | 4.525B |
| March 26, 2026 | 4.531B |
| March 25, 2026 | 4.531B |
| March 24, 2026 | 4.525B |
| March 23, 2026 | 4.528B |
| March 20, 2026 | 4.531B |
| March 19, 2026 | 4.515B |
| March 18, 2026 | 4.512B |
| March 17, 2026 | 4.512B |
| March 16, 2026 | 4.512B |
| March 13, 2026 | 4.512B |
| March 12, 2026 | 4.512B |
| March 11, 2026 | 4.512B |
| March 10, 2026 | 4.509B |
| March 09, 2026 | 4.512B |
| March 06, 2026 | 4.503B |
| March 05, 2026 | 4.500B |
| March 04, 2026 | 4.500B |
| March 03, 2026 | 4.503B |
| March 02, 2026 | 4.509B |
| February 27, 2026 | 4.512B |
| February 26, 2026 | 4.500B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioMarin Pharmaceutical, Inc. | 12.70B |
| Insmed, Inc. | 27.15B |
| Ligand Pharmaceuticals, Inc. | 5.734B |
| PTC Therapeutics, Inc. | 6.057B |
| Establishment Labs Holdings, Inc. | 2.159B |
Market Cap Related Metrics
| PS Ratio | 7.087 |
| Price to Book Value | 16.59 |
| Price to Free Cash Flow | 150.58 |
| Price | 14.49 |
| Earnings Yield | -0.61% |
| Operating PE Ratio | 130.31 |